News Image

Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements

Provided By GlobeNewswire

Last update: Aug 6, 2025

Record quarterly net product sales of $102.7 million achieved within two years of our XDEMVY® launch, an increase of 152% year over year

Read more at globenewswire.com

TARSUS PHARMACEUTICALS INC

NASDAQ:TARS (11/18/2025, 8:00:01 PM)

After market: 76.97 0 (0%)

76.97

+2.8 (+3.78%)



Find more stocks in the Stock Screener

TARS Latest News and Analysis

Follow ChartMill for more